These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3111746)

  • 1. Pharmacologic thrombolysis: tissue-type plasminogen activator.
    Sobel BE
    Circulation; 1987 Aug; 76(2 Pt 2):II39-43. PubMed ID: 3111746
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary thrombolysis with tissue-type plasminogen activator.
    Bergmann SR; Ludbrook PA; Sobel BE
    Cardiol Clin; 1987 Feb; 5(1):101-11. PubMed ID: 3103916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator for acute coronary thrombosis. The Medical Letter.
    Conn Med; 1988 Feb; 52(2):105-6. PubMed ID: 3126023
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue plasminogen activator for coronary thrombosis.
    DiPalma JR
    Am Fam Physician; 1988 Mar; 37(3):291-5. PubMed ID: 3126630
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary thrombolysis by t-PA and pro-UK].
    Kanmatsuse K; Suzuki T; Kajiwara N
    Nihon Rinsho; 1989 Apr; 47(4):910-6. PubMed ID: 2501541
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary thrombolysis.
    Thomas P; Sheridan DJ
    Q J Med; 1988 Sep; 68(257):657-63. PubMed ID: 2978484
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator.
    Thompson PL
    Lancet; 1988 Aug; 2(8609):519. PubMed ID: 2900452
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator.
    Waugh NR
    Lancet; 1988 Mar; 1(8586):653. PubMed ID: 2894587
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary thrombolysis with tissue-type plasminogen activator: an overview.
    Van de Werf F; Collen D
    Eur Heart J; 1985 Nov; 6(11):902-4. PubMed ID: 3935445
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
    Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary thrombolysis.
    Ann Intern Med; 1990 Jul; 113(2):171. PubMed ID: 2113785
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis. An approach still on the move.
    Verstraete M
    Drugs; 1989 Feb; 37(2):116-22. PubMed ID: 2495217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reocclusion after treatment with actilyse].
    Raynaud P; Desveaux B
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():25-32. PubMed ID: 3142416
    [No Abstract]   [Full Text] [Related]  

  • 15. The Jeremiah Metzger lecture. Thrombolysis and dilatation in coronary occlusion.
    Ross RS
    Trans Am Clin Climatol Assoc; 1987; 98():151-66. PubMed ID: 2956749
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary thrombolysis with tissue-type plasminogen activator (t-PA): emerging strategies.
    Sobel BE
    J Am Coll Cardiol; 1986 Nov; 8(5):1220-5. PubMed ID: 3093555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
    Chesebro JH; Fuster V
    J Am Coll Cardiol; 1990 Sep; 16(3):723-5. PubMed ID: 2117621
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis.
    Yao SK; Ober JC; Ferguson JJ; Maffrand JP; Anderson HV; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1993; 106():110-9. PubMed ID: 8036734
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.